Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

164.65
-4.1900-2.48%
Post-market: 164.650.00000.00%19:16 EDT
Volume:393.05K
Turnover:65.60M
Market Cap:9.85B
PE:-24.35
High:168.97
Open:168.01
Low:163.93
Close:168.84
Loading ...

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
Yesterday

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live
·
17 Mar

European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading

MT Newswires Live
·
13 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week

MT Newswires Live
·
08 Mar

TD Cowen Sticks to Its Buy Rating for Ascendis Pharma (ASND)

TIPRANKS
·
05 Mar

Exploring US High Growth Tech Stocks In March 2025

Simply Wall St.
·
04 Mar

Ascendis Pharma (ASND) Receives a Hold from Morgan Stanley

TIPRANKS
·
03 Mar

Ascendis Pharma Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
25 Feb

Morgan Stanley Sticks to Their Hold Rating for Ascendis Pharma (ASND)

TIPRANKS
·
24 Feb

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Medtronic (MDT) and Tyra Bioscience (TYRA)

TIPRANKS
·
19 Feb

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
19 Feb

Ascendis Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
18 Feb

Ascendis Pharma A/S (NASDAQ:ASND) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall St.
·
15 Feb

Ascendis Pharma Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
14 Feb

Evercore ISI Remains a Buy on Ascendis Pharma (ASND)

TIPRANKS
·
14 Feb

Ascendis Pharma AS (ASND) Q4 2024 Earnings Call Highlights: Strategic Growth and Market ...

GuruFocus.com
·
14 Feb